BOB体育

Skip to main content

Vidhu Kariyawasam, MD

Infectious Disease Specialist

Photo of Vidhu Kariyawasam

Active clinical trials

RECOVER-AD

This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This鈥�

Investigators
Vidhu Kariyawasam, Kartik Cherabuddi
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

8 publications

2024

A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe Pneumonia.

Therapeutic drug monitoring

鈥�

2024

Myocarditis Secondary to Human Monocytotrophic Ehrlichiosis.

Cureus

鈥�

2023

Perianal ulcer and proctocolitis in an immunocompromised patient.

JAAD case reports

鈥�

2022

A longitudinal interprofessional case based learning experience: The HIV/AIDS care continuum in the rural South

Journal of Interprofessional Education & Practice

2021

Post-COVID seizure: A new feature of "long-COVID".

eNeurologicalSci

鈥�